Bryan A Chan Clinical Oncology Society of Australia Annual Scientific Meeting 2026

Abstracts this author is presenting:

• A phase 2/3 trial of a PD-1/VEGF bispecific antibody (PF-08634404) in combination with chemotherapy in first-line for extensive-stage small cell lung cancer (ES-SCLC; Symbiotic-Lung-04)  — Wednesday Poster Session
• The LAMp-LC Study: Unveiling the lung microbiome in Australians with early- and late-stage lung cancer — Wednesday Poster Session